These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18173425)

  • 21. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
    Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
    Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
    [No Abstract]   [Full Text] [Related]  

  • 22. Orally active prostacyclin analogue in primary pulmonary hypertension.
    Okano Y; Yoshioka T; Shimouchi A; Satoh T; Kunieda T
    Lancet; 1997 May; 349(9062):1365. PubMed ID: 9149701
    [No Abstract]   [Full Text] [Related]  

  • 23. Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.
    Fisher KA; Serlin DM; Wilson KC; Walter RE; Berman JS; Farber HW
    Chest; 2006 Nov; 130(5):1481-8. PubMed ID: 17099027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary arterial hypertension in a Kartagener syndrome patient: treatment with beraprost sodium.
    Shen YC; Wen FQ; Yi Q
    Int J Cardiol; 2012 Aug; 159(1):e9-10. PubMed ID: 22104985
    [No Abstract]   [Full Text] [Related]  

  • 26. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report.
    Badalian SS; Silverman RK; Aubry RH; Longo J
    J Reprod Med; 2000 Feb; 45(2):149-52. PubMed ID: 10710749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epoprostenol-induced hypersplenism in portopulmonary hypertension.
    Touma W; Nayak RP; Hussain Z; Bacon BR; Kudva GC
    Am J Med Sci; 2012 Nov; 344(5):345-9. PubMed ID: 22227513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.
    Farber HW; Graven KK; Kokolski G; Korn JH
    J Rheumatol; 1999 May; 26(5):1195-6. PubMed ID: 10332990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical acute brain thromboembolism during prostacyclin (PGI2) acute challenge for primary pulmonary hypertension.
    Raffy O; Sleiman C; Mal H; Fournier M; Pariente R
    Eur Heart J; 1996 Jan; 17(1):153-4. PubMed ID: 8682124
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular?
    Rich S
    Circ Heart Fail; 2009 Mar; 2(2):145-50. PubMed ID: 19808330
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcomes in children with idiopathic pulmonary arterial hypertension.
    Yung D; Widlitz AC; Rosenzweig EB; Kerstein D; Maislin G; Barst RJ
    Circulation; 2004 Aug; 110(6):660-5. PubMed ID: 15289375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
    Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
    Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
    Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
    Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 36. [The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart].
    Ricksten S
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):460-1. PubMed ID: 11792300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension.
    Findlay JY; Plevak DJ; Krowka MJ; Sack EM; Porayko MK
    Liver Transpl Surg; 1999 Sep; 5(5):362-5. PubMed ID: 10477835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.
    Garabedian MJ; Hansen WF; Gianferrari EA; Lain KY; Fragneto RY; Campbell CL; Booth DC
    J Perinatol; 2010 Sep; 30(9):628-31. PubMed ID: 20802509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery.
    Kim SY; Shim JK; Shim YH; Hong SW; Choi KH; Kwak YL
    J Heart Valve Dis; 2010 May; 19(3):333-40. PubMed ID: 20583396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of early inhaled epoprostenol therapy on pulmonary artery pressure and blood loss during LVAD placement.
    Groves DS; Blum FE; Huffmyer JL; Kennedy JL; Ahmad HB; Durieux ME; Kern JA
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):652-60. PubMed ID: 24103713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.